Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth Corp (NASDAQ: CGC) shares are trading higher Wednesday in anticipation of a Senate marijuana meeting. The Senate Judiciary Subcommittee on Crime and Terrorism has scheduled a meeting, titled "Decriminalizing Cannabis at the Federal Level: Necessary Steps to Address Past.

Why Canopy Growth Stock Is On Fire Today

Aurora Cannabis

With so many businesses going all-in on cannabis and stock price performance fledgling, many investors have been left scratching their heads. Let's look at two of the most prominent cannabis stocks to see if the sea of red will ever shift to green.

Is There Finally Green Ahead for These 2 Cannabis Leaders?

Qudian

Exela Technologies

Here's what you need to know about buying penny stocks on July 19th The post What to Know About Buying Penny Stocks on July 19th  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

What to Know About Buying Penny Stocks on July 19th

Retirement of Approximately $263 Million of Debt Strengthens Canopy Growth's Balance Sheet and Preserves Cash to Support Future Growth SMITHS FALLS, ON , July 18, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today that it has closed (the "Final Closing") its previously announced exchange transaction (the "Transaction") of certain 4.25% unsecured notes due 2023 (the "Notes") in order to reduce its debt obligations by approximately $263 million. Constellation Brands, Inc. ("CBI"), through its wholly-owned subsidiary Greenstar Canada Investment Limited Partnership ("GCILP"), participated in the Transaction.

Canopy Growth Announces Closing of Previously Announced Exchange Transaction

Tilray Brands

SNDL Inc.

Although political speculation has spiked up weed stocks, investors ought to recognize the steep challenges of marijuana legalization. The post Why Are Weed Stocks TLRY, CGC, SNDL Up Today?

Why Are Weed Stocks TLRY, CGC, SNDL Up Today?

Today, investors in Canopy Growth and CGC stock have seen a 15% bump, as a number of key catalysts get priced in. The post Why Is Canopy Growth (CGC) Stock Up 15% Today?

Why Is Canopy Growth (CGC) Stock Up 15% Today?

Speculators are pouring into cannabis stocks today ahead of a possible landmark vote in the U.S. Senate.

Why Aurora Cannabis, Canopy Growth, and Sundial Growers Are Rolling Higher Today

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Headwinds abound, and good news might be hard to find for a while.

Is Now the Right Time to Dump Your Cannabis Stocks?

Top Canadian Cannabis Companies In The Stock Market Today The post 3 Canadian Marijuana Stocks That Could Be Top Movers This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks That Could Be Top Movers This Week

The drop is a continuation of the stock's downward trend this year.

Why Shares of Canopy Growth Sank 18.7% This Week

Cronos Group

After a horrible 2021 for cannabis investors, the AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) is down another 55.1% in 2022. President Joe Biden and a Democrat-controlled Congress have made little progress on U.S. federal cannabis reform.

Cannabis Stock Short Sellers Have $807M In Profits So Far In 2022

Canada's top marijuana stocks are giving back some of their recent gains.

Here's Why Aurora Cannabis, Canopy Growth, Tilray Brands, and Sundial Growers Are All Tanking Today

Short interest in cannabis stocks has fallen in a sign that investors are placing fewer bets that the sector will weaken, according to fresh numbers this week.

Short positions ease back on cannabis stocks, but shares remain deeply in the red

OrganiGram Holdings Inc.

Democrats in the U.S. Senate will reportedly introduce a bill for marijuana legalization as soon as next week.

Here's What Moved Sundial Growers, Organigram, and Canopy Growth Stocks Today

Shares of Tilray Brands jumped as much as 20%, while Aurora Cannabis spiked 10%, and Canopy Growth climbed 7%.

Cannabis stocks spike on report that Senate Democrats are planning to introduce a bill for federal decriminalization

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ: CRON), Sundial Growers Inc (NASDAQ: SNDL) and Tilray Inc (NASDAQ: TLRY), are trading higher Thursday.

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Shooting Up

Geron

IAMGOLD

Mullen Automotive

Platinum Group Metals

ECA Marcellus Trust

If you think the volatility in the broader indices isn't enough excitement, here are the best penny stocks to consider under $3. The post 7 Best Penny Stocks Under $3 to Buy in July appeared first on InvestorPlace.

7 Best Penny Stocks Under $3 to Buy in July

Constellation Brands is doing better than many expected it to, after all.

Is Canopy Growth About to Shoot Higher Because of Its Partner's Outperformance?

Argo Blockchain PLC

Avis Budget Group

EyePoint Pharmaceuticals

Rivian Automotive

Petco Health and Wellness

Weightwatchers International Inc.

For speculators that are seeking the next big upside opportunity, you may consider these oversold Nasdaq stocks to buy now. The post 7 Wildly Oversold Nasdaq Stocks to Buy Now appeared first on InvestorPlace.

7 Wildly Oversold Nasdaq Stocks to Buy Now

These top marijuana stocks are dropping yet again.

Why Shares of Aurora Cannabis, Canopy Growth, and Sundial Growers Are Slumping Today

Pot Stocks In Mid July 2022 The post Top Canadian Cannabis Stocks To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Cannabis Stocks To Watch Right Now

Anheuser-Busch InBev

Constellation Brands

Molson Coors Brewing

We still think the industry will grow significantly in the coming years. But we don't think cannabis stocks will score investors big returns.

Ditch the Losing Game in Cannabis Stocks for Much Greener Pastures

Multiple headwinds weighed on the cannabis giant's shares last month.

Why Canopy Growth Stock Cratered in June

HEXO Corp

Canadian Marijuana Stocks To Keep On Your Radar The post 3 Canadian Marijuana Stocks To Buy In July? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks To Buy In July?

Canaccord Genuity (TSX:CF, LSE:CF) slashed its price target on Canopy Growth Corp following news of the cannabis company's plan to convert nearly C$253 million of unsecured convertible notes into equity – a move analysts decried as dilutive. The investment bank downgraded its target to C$3.50 from C$4.50 and reiterated its ‘Sell' rating on the stock.

Canopy Growth price target slashed to C$3.50 by Canaccord Genuity after converting unsecured notes into equity

News for Canopy Growth Stock (CGC)